RemeGen Co., Ltd. (HKG:9995)
Hong Kong · Delayed Price · Currency is HKD 83.70
-1.05 (-1.24%)
Aug 11, 2026, 4:08 PM HKT
RemeGen Market Cap
RemeGen has a market cap or net worth of 71.7 billion as of August 11, 2026. Its market cap has increased by 92.33% in one year.
Market Cap
71.70B
Enterprise Value
70.96B
Revenue
3.84B
Ranking
n/a
PE Ratio
31.54
Stock Price
83.70
ChartMarket Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 33.39B to 71.70B, an increase of 114.73%. That is a compound annual growth rate of 14.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 71.70B | 58.62% |
| Dec 31, 2025 | 45.20B | 222.75% |
| Dec 31, 2024 | 14.00B | -55.02% |
| Dec 29, 2023 | 31.13B | -25.43% |
| Dec 30, 2022 | 41.75B | 9.42% |
| Dec 31, 2021 | 38.16B | -18.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WuXi Biologics | 189.26B |
| Innovent Biologics | 166.34B |
| Sichuan Kelun-Biotech Biopharmaceutical | 126.32B |
| Akeso | 93.50B |
| Sino Biopharmaceutical | 89.92B |
| Biocytogen Pharmaceuticals (Beijing) | 61.15B |
| Genscript Biotech | 52.87B |
| 3SBio | 44.86B |